Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.96
0.18 (2.31%)
At close: Aug 15, 2025, 3:59 PM
8.00
0.57%
After-hours: Aug 15, 2025, 07:58 PM EDT

Capricor Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 11.13M 2.26M 3.97M 4.91M 12.09M 6.19M 3.92M 2.99M 959.9K 1.59M n/a n/a n/a n/a 204.08K 40.82K
Cost of Revenue
n/a 405.45K 375.7K 361.17K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a -405.45K 10.76M 1.9M 3.62M 4.91M 11.78M 5.91M 3.67M 2.76M 774.82K 1.43M n/a n/a n/a n/a 204.08K 40.82K
Operating Income
-27.72M -24.98M -7.7M -13.01M -11.59M -10.27M -1.28M -6.87M -7.75M -8.19M -8.07M -6.48M -7.32M -7.83M -6.38M -4.32M -5.08M -5.16M
Interest Income
1.79M 729.54K 686.57K 453.15K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-25.91M -24.39M -7.12M -12.56M -11M -9.79M -762K -6.39M -7.37M -7.77M -7.72M -6.37M -7.11M -7.82M -6.19M -3.93M -4.75M -5.15M
Net Income
-25.91M -24.39M -7.12M -12.56M -11M -9.79M -762K -6.39M -7.37M -7.77M -7.72M -6.37M -7.11M -7.82M -6.19M -3.93M -4.75M -5.15M
Selling & General & Admin
5.67M 5.88M 4.09M 3.3M 2.9M 3.92M 2.99M 2.91M 2.75M 3.42M 2.79M 2.56M 2.36M 2.72M 2.12M 1.8M 1.79M 1.91M
Research & Development
22.05M 18.92M 14.55M 11.81M 12.51M 11.1M 9.94M 10.03M 8.82M 7.66M 6.23M 5.5M 4.96M 5.12M 4.26M 2.51M 3.5M 3.3M
Other Expenses
n/a 189.95K -193.66K -200.86K 156.8K 152.24K 442.37K 113.68K 97.3K 92.35K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
27.72M 24.98M 18.45M 14.91M 15.56M 15.17M 13.37M 13.05M 11.66M 11.17M 9.03M 8.07M 7.32M 7.83M 6.38M 4.32M 5.29M 5.2M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
27.72M 24.98M 18.83M 15.27M 15.56M 15.17M 13.37M 13.05M 11.66M 11.17M 9.03M 8.07M 7.32M 7.83M 6.38M 4.32M 5.29M 5.2M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
45.71M 45.64M 35.22M 33.09M 31.84M 31.36M 26.78M 25.82M 25.34M 25.25M 25.16M 24.43M 24.32M 24.28M 24.15M 23.09M 22.86M 22.23M
Shares Outstanding (Diluted)
45.71M 45.64M 35.22M 33.09M 31.84M 31.36M 26.78M 25.82M 25.34M 25.25M 25.16M 24.43M 24.32M 24.28M 24.15M 23.09M 22.86M 22.23M
EPS (Basic)
-0.57 -0.53 -0.16 -0.38 -0.35 -0.31 -0.02 -0.25 -0.29 16.19 -0.31 -0.26 -0.28 -0.32 -0.26 -0.17 -0.21 -0.23
EPS (Diluted)
-0.57 -0.53 -0.16 -0.38 -0.35 -0.31 -0.02 -0.25 -0.29 16.19 -0.31 -0.26 -0.28 -0.32 -0.26 -0.17 -0.21 -0.23
EBITDA
-25.93M -24.58M -7.32M -12.65M -11.23M -9.93M -974K -6.59M -7.49M -7.96M -7.88M -6.34M -7.21M -7.74M -6.3M -4.25M -5.03M -5.11M
EBIT
-25.93M -24.98M -7.7M -13.01M -11.59M -10.27M -1.28M -6.87M -7.75M -8.19M -8.07M -6.48M -7.32M -7.83M -6.38M -4.32M -5.08M -5.16M
Depreciation & Amortization
n/a 405.45K 375.7K 361.17K 356.94K 331.41K 307.61K 276.47K 254.7K 230.1K 191.6K 137.03K 112.01K 92.49K 78.64K 64.72K 52.2K 50.14K